| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $36.2M | — | +77.5% |
| R&D Expense | $4.4M | — | +34.8% |
| SG&A Expense | $20.8M | — | +6.3% |
| Operating Income | $52.1M | — | +1072.5% |
| Pre-tax Income | $44.8M | — | +2437.2% |
| Income Tax | $6.9M | — | +484.9% |
| Net Income | $37.9M | — | +1322.7% |
| EPS (Basic) | $0.62 | — | +1133.3% |
| EPS (Diluted) | $0.60 | — | +1100.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $95.6M | +53.2% | +156.0% |
| Accounts Receivable | $22.1M | -5.0% | +75.1% |
| Inventory | $2.3M | +32.8% | -9.7% |
| Current Assets | $230.0M | +3.1% | +181.9% |
| Total Assets | $278.6M | -2.2% | +61.3% |
| Current Liabilities | $47.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $6.1M | — | +174.7% |
| Capital Expenditures | $35K | — | -64.6% |
| Investing Cash Flow | $79.6M | — | +655.2% |
| Financing Cash Flow | -$52.8M | — | -3385.9% |
| Free Cash Flow | $6.1M | — | +173.4% |
| +74.3% |
| Long-term Debt | $61.9M | +0.0% | +3.1% |
| Total Liabilities | $72.8M | -44.1% | -44.7% |
| Stockholders' Equity | $205.8M | +33.1% | +401.7% |